Literature DB >> 27828658

Dermal tunneling: a proposed treatment for depressed scars.

Emerson Vasconcelos de Andrade Lima1.   

Abstract

Depressed facial scars are still a challenge in medical literature, despite the wide range of proposed treatments. Subcision is a technique that is frequently performed to improve this type of lesions. This article proposes a new method to release depressed scars, reported and named by the author as dermal tunneling. This study presents a simple and didactic manner to perform this method. The results in 17 patients with facial scars were considered promising. Thus, the technique was deemed to be safe and reproducible.

Entities:  

Mesh:

Year:  2016        PMID: 27828658      PMCID: PMC5087243          DOI: 10.1590/abd1806-4841.20164959

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  6 in total

Review 1.  Postacne scarring: a review of its pathophysiology and treatment.

Authors:  G J Goodman
Journal:  Dermatol Surg       Date:  2000-09       Impact factor: 3.398

2.  A better way to hold a Nokor needle during subcision.

Authors:  Khalid M AlGhamdi; Khalid M Al Ghamdi
Journal:  Dermatol Surg       Date:  2008-01-07       Impact factor: 3.398

Review 3.  Treatment of facial scarring: lasers, filler, and nonoperative techniques.

Authors:  Jason S Cooper; Bernard T Lee
Journal:  Facial Plast Surg       Date:  2009-12-18       Impact factor: 1.446

4.  Subcision: a treatment for cellulite.

Authors:  D M Hexsel; R Mazzuco
Journal:  Int J Dermatol       Date:  2000-07       Impact factor: 2.736

5.  Subcision in acne scar with and without subdermal implant: a clinical trial.

Authors:  K Balighi; R M Robati; H Moslehi; A M Robati
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-03-10       Impact factor: 6.166

6.  Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles.

Authors:  D S Orentreich; N Orentreich
Journal:  Dermatol Surg       Date:  1995-06       Impact factor: 3.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.